Randomised, placebo-controlled, double-blind clinical trial of β-sitosterol in patients with benign prostatic hyperplasia
- 1 June 1995
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 345 (8964) , 1529-1532
- https://doi.org/10.1016/s0140-6736(95)91085-9
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A three month double‐blind study of doxazosin as treatment for benign prostatic bladder outlet obstructionBritish Journal of Urology, 1994
- Doxazosin Treatment in Patients with Prostatic ObstructionScandinavian Journal of Urology and Nephrology, 1993
- Finasteride (MK‐906) in the treatment of benign prostatic hyperplasiaThe Prostate, 1993
- Alfuzosin for treatment of benign prostatic hypertrophyThe Lancet, 1991
- Role of alpha-adrenergic blockers in the treatment of benign prostatic hyperplasiaThe Prostate, 1990
- The Development of Human Benign Prostatic Hyperplasia with AgeJournal of Urology, 1984
- A Placebo‐controlled Double‐blind Study of the Effect of Phenoxybenzamine in Benign Prostatic ObstructionBritish Journal of Urology, 1978
- The Incidence of Benign Prostatic ObstructionJournal of Urology, 1968